Cancers | |
Diagnostic Value of 11C-Methionine (MET) and 18F-Fluorothymidine (FLT) Positron Emission Tomography in Recurrent High-Grade Gliomas; Differentiation from Treatment-Induced Tissue Necrosis | |
Hajime Shishido1  Nobuyuki Kawai1  Keisuke Miyake1  Yuka Yamamoto2  Yoshihiro Nishiyama2  | |
[1] Department of Neurological Surgery, Faculty of Medicine, Kagawa University, 1750-1 Miki-cho, Kita-Gun, Kagawa 761-0793, Japan; E-Mails:;Department of Radiology, Faculty of Medicine, Kagawa University, 1750-1 Miki-cho, Kita-Gun, Kagawa 761-0793, Japan; E-Mails: | |
关键词: fluorothymidine (FLT); malignant glioma; methionine (MET); necrosis; positron emission tomography; recurrence; | |
DOI : 10.3390/cancers4010244 | |
来源: mdpi | |
【 摘 要 】
We retrospectively evaluated the usefulness of combined measurement of L-methyl-[11C]methionine (MET) and 3'-deoxy-3'-[18F]fluorothymidine (FLT) positron emission tomography (PET) in the differential diagnosis between recurrent gliomas and necrotic lesions. Twenty-one patients with high-grade glioma, previously treated with surgery and radiotherapy with chemotherapy and first radiological suspicion of recurrence were enrolled. The uptake was assessed by the maximum standardized uptake value (SUVmax) and lesion-to-normal tissue count density ratio (L/N ratio). Of the 21 lesions, 15 were diagnosed recurrent gliomas and six were necrotic lesions. The average SUVmax was not significantly different between recurrent gliomas and necrotic lesions on either MET-PET or FLT-PET. The average L/N ratio of recurrent gliomas (3.36 ± 1.06) was significantly higher than that of necrotic lesions (2.18 ± 0.66) on MET-PET (
【 授权许可】
CC BY
© 2012 by the authors; licensee MDPI, Basel, Switzerland.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202003190045782ZK.pdf | 1959KB | download |